venBio Global Strategic GP II, Ltd., 10% Owner at Checkmate Pharmaceuticals, Inc. (CMPI), bought 3,673,374 shares at $15.00 ($3.0M) on 2020-08-11, disclosed to the SEC on 2020-08-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,473,374 | $0 | 0.0% |
| 2 | $15.00 | 200,000 | $3.0M | 100.0% |
| Total | $0.82 avg | 3,673,374 | $3.0M | 100% |
| Filing → |
| AKRO | BUY | 2019-06-25 | $4.0M | — | Filing → |